|Articles|November 1, 2017
Almac Group Announces Acquisition of BioClin Laboratories
Advertisement
Almac Group announced the acquisition of 100% shares of BioClin Laboratories. BioClin will bring fourth its expert analytical services and analysis to increase Almac’s capacity and compliment its existing business strategic expansion which will help them to serve clients globally.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
Using AI and Tokenized Data to Match Patients to Protocols
4
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
